Literature DB >> 23839187

Vitiligo surgical, laser, and alternative therapies: a review and case series.

Cindy Wassef1, Adriana Lombardi, Sairah Khokher, Babar K Rao.   

Abstract

INTRODUCTION: Vitiligo is a condition caused by the destruction of melanocytes, resulting in areas of skin without pigmentation. While many topical therapies exist for its treatment, not all patients respond to such treatments. Various surgical, laser and other alternative therapies are available for use as well.
OBJECTIVE: The objective of this review was to describe the various surgical, laser, and alternative therapies available for vitiligo. A literature review was conducted through Pubmed and Ovid using the search terms "Vitiligo treatment", "Vitiligo surgery", "Vitiligo laser". Since no articles were available about needling on both Pubmed and Ovid using the search criteria, individual articles were sought out through Google.
RESULTS: The literature review yielded many possible surgical interventions including autologous mini-punch grafting, suction epidermal blister grafting, split-thickness grafting, and cultured and noncultured melanocyte keratinocyte transfer. Laser options included the helium-neon and xenon-chloride lasers, with tattooing and needling serving as other options. While all the above techniques can provide improvement to pigmentation in vitiliginous patches, physician comfort and experience are important factors with regards to outcome. Our case series of four patients treated with the needling method yielded favorable results, with repigmentation rates ranging from 25-50%, with one patient having 90% repigmentation.
CONCLUSION: There are many surgical, laser, and alternative treatment options available for vitiligo when conventional medical therapy fails or for use in conjunction with medical therapies. Autologous mini punch grafting and needling both have minimal equipment requirements and are easy to learn. Physician experience and comfort play a large role in outcome and availability of services.

Entities:  

Mesh:

Year:  2013        PMID: 23839187

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  6 in total

1.  [Treatment of vitiligo].

Authors:  M Meurer; M Schild
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

Review 2.  Advances in Vitiligo: An Update on Medical and Surgical Treatments.

Authors:  Alexander B Dillon; Andrew Sideris; Ali Hadi; Nada Elbuluk
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

Review 3.  Recent advances in understanding vitiligo.

Authors:  Prashiela Manga; Nada Elbuluk; Seth J Orlow
Journal:  F1000Res       Date:  2016-09-06

4.  CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.

Authors:  Jonathan M Eby; Hee-Kap Kang; Sean T Tully; Wendy E Bindeman; Daniel S Peiffer; Shilpak Chatterjee; Shikhar Mehrotra; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2015-01-09       Impact factor: 8.551

5.  Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo.

Authors:  K H Mou; D Han; W L Liu; P Li
Journal:  Braz J Med Biol Res       Date:  2016-07-25       Impact factor: 2.590

6.  An Innovative Therapeutic Protocol for Vitiligo: Experience with the Use of Fraxel Herbium Laser, Topical Latanoprost and Successive Irradiation with UVA - 1 Laser.

Authors:  Torello Lotti; Uwe Wollina; Georgi Tchernev; Yan Valle; Jacopo Lotti; Katlein França; Francesca Satolli; Miriam Rovesti; Michael Tirant; Ilia Lozev; Ivan Pidakev; Serena Gianfaldoni
Journal:  Open Access Maced J Med Sci       Date:  2018-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.